Neoplasia/BPH

	SEROLOGICAL OUTCOMES OF TREATMENT WITH 3D-CRT AND IMRT IN LOCALIZED PROSTATE CANCER. J Ayub Med Coll Abbottabad Hanif S, Osmani AH, Malick J. PMID: 39623820 [PubMed - indexed for MEDLINE]
	Severe Xanthogranulomatous prostatitis mimicking prostate cancer: a case report. J Med Case Rep Hassan WA, Elmetwally AA, Abdelhafeez MAM, Ali OKA. PMID: 39623396 [PubMed - indexed for MEDLINE]
	A two-phase point-of-care diagnostic device for bladder cancer. Nat Biomed Eng PMID: 39623096 [PubMed - as supplied by publisher]
	Salvage irreversible electroporation for locally recurrent prostate cancer after definitive radiotherapy: a systematic review. Prostate Cancer Prostatic Dis Yilmaz M, Karaaslan M, , Aybal HÇ, Polat ME, Tonyali S, Hatiboglu G. PMID: 39623055 [PubMed - as supplied by publisher]
	Irish Prostate Cancer Outcomes Research (IPCOR) registry: cohort profile. BMJ Open Gordon N, Dooley C, Murphy Á, Farooq W, Sullivan F, McDermott R, Sharp L, Watson W, Galvin D. PMID: 39622568 [PubMed - indexed for MEDLINE]
	General Practitioners' Experiences With Implementing Colon or Prostate Cancer Survivorship Care in Primary Care: A Cross-Sectional Survey Nested Within Two Randomized-Controlled Trials. JCO Oncol Pract Vos JAM, Wollersheim BM, van Weert HCPM, van de Poll-Franse LV, van Asselt KM. PMID: 39621954 [PubMed - as supplied by publisher]
	Analysis of Genitourinary Rhabdomyosarcoma in Phase 3 clinical trials. World J Urol Campbell T, Hunt TC, Li A, Cheng Z, Malshy K, Doersch K, Bandari J. PMID: 39621093 [PubMed - indexed for MEDLINE]
	Surgical and oncological outcomes of salvage radical prostatectomy after focal therapies: a matched-pair analysis. World J Urol Ambrosini F, Hagemann J, Pose R, Maurer T, Heinzer H, Michl U, Steuber T, Budäus L, Terrone C, Tennstedt P, Haese A, Tilki D, Graefen M, Nagaraj Y, Salomon G. PMID: 39621043 [PubMed - indexed for MEDLINE]
	Relationship between neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in peripheral blood and prognosis after castration therapy for prostate cancer. Indian J Cancer Wu H, Gong M, Yuan R. PMID: 39620727 [PubMed - indexed for MEDLINE]
	Tumor Microenvironment in Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis. Iran J Public Health Guo Z, Wang X, Huang S, Weng G. PMID: 39619906 [PubMed]
	Galectin-3 marker expression in renal cell carcinoma and correlation with patient's clinicopathologic factors: A cross-sectional study. Caspian J Intern Med Kamrani G, Havaspour R, Ranaee M, Shafi H, Shirafkan H, Sohrabi ME, Jahansouz D. PMID: 39619762 [PubMed]
	A pooled analysis of pancreatic resection for metastatic renal cell carcinoma. Front Oncol Zhou Y, Wang X, Chen S, Wang S. PMID: 39619443 [PubMed]
	Health-related quality of life outcomes in randomized controlled trials in metastatic hormone-sensitive prostate cancer: a systematic review. EClinicalMedicine Osanto S, Vliert-Bout AV, Gomez de Segura CA, Efficace F, Sparano F, Willemse PP, Schoones J, Cohen A, Barjesteh van Waalwijk van Doorn-Khosrovani S. PMID: 39619239 [PubMed]
	Comparative efficacy and safety of 180Â W XPS vs. 120 W HPS GreenLight laser therapy for benign prostatic hyperplasia: a systematic review and meta-analysis. PeerJ Wang M, Xi Y, Qiu Z, Huang N, Zhang L, Liu J. PMID: 39619178 [PubMed - indexed for MEDLINE]
	Epidemiology and Treatment Outcomes of Renal Cell Carcinoma in Qassim Region, Saudi Arabia: A Retrospective Study. Cureus Alharbi B, Alnosayan HS, Al-Harbi FA, Alaidah AM, Almoshiqeh AN, Alharbi AM, Alwashmi E, Altwairgi AK. PMID: 39618569 [PubMed]
	Change in Cardiorespiratory Fitness and the Risk of Colorectal and Prostate Cancer Incidence in Men. Cancer Med Bojsen-Møller E, Bolam KA, Väisänen D, Paulsson S, Lindwall M, Rundqvist H, Nyberg J, Åberg M, Ekblom-Bak E. PMID: 39618343 [PubMed - indexed for MEDLINE]
	An Application of Machine-Learning-Oriented Radiomics Model in Clear Cell Renal Cell Carcinoma (ccRCC) Early Diagnosis. Br J Hosp Med (Lond) Qiu G, Dai Z, Zhang H. PMID: 39618212 [PubMed - indexed for MEDLINE]
	Prospective Study of Patient, Nursing, and Oncology Provider Perspectives on Telemedicine Visits for Renal Cell Carcinoma Clinical Trials. Clin Genitourin Cancer Doshi SD, Knezevic A, Gonzalez C, Fischer P, Goodman R, Gornell S, Patel S, Puzio C, Ritea A, Lee CH, Evans L, Voss MH, Motzer RJ, Kotecha RR. PMID: 39616970 [PubMed - as supplied by publisher]
	Evaluating the quality of prostate cancer diagnosis recording in CPRD GOLD and CPRD Aurum primary care databases for observational research: A study using linked English electronic health records. Cancer Epidemiol Somathilake G, Ford E, Armes J, Moschoyiannis S, Collins M, Francsics P, Lemanska A. PMID: 39616870 [PubMed - as supplied by publisher]
	Evaluating the dosimetric impact of deep-learning-based auto-segmentation in prostate cancer radiotherapy: Insights into real-world clinical implementation and inter-observer variability. J Appl Clin Med Phys Arjmandi N, Mosleh-Shirazi MA, Mohebbi S, Nasseri S, Mehdizadeh A, Pishevar Z, Hosseini S, Tehranizadeh AA, Momennezhad M. PMID: 39616629 [PubMed - as supplied by publisher]

Articles 1 - 20 / 172588

Page 1 of 8630



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy